Dr Reddys Laboratories (RDY) Cash from Operations (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Cash from Operations of -$9.79 million in the quarter ended Jun 30, 2026, compared with $170.94 million a year earlier.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Cash from Operations (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Cash from Operations came in at $462.38 million as of Jun 30, 2026, down 24.8% year-over-year; for the year ended Mar 31, 2026, it came in at $607 million, up 11.4% from the prior year.
- Annual Cash from Operations has a five-year compound annual growth rate of 4.5% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Cash from Operations came in at $545 million in the year ended Mar 31, 2025 (unchanged), $545 million in the year ended Mar 31, 2024 (-23.9%), $716 million in the year ended Mar 31, 2023 (+93.5%) and $370 million in the year ended Mar 31, 2022 (-24.2%).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Cash from Operations since the quarter ended Jun 30, 2021.
- On a year-over-year basis, Cash from Operations rose in four of the last seven quarters, with growth averaging 43.8%.
- Peak year-over-year performance for Cash from Operations in the last five years was growth of 300.1% in the quarter ended Dec 31, 2021, against a decline of 68.6% in the quarter ended Mar 31, 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $171.14 million (quarter ended Mar 31, 2026), $122.47 million (quarter ended Dec 31, 2025) and $178.56 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 8.62 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.44 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 5.37 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 5.88 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 4.58 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 4.00 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 3.57 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 835.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 1.13 Bn |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | -9.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.79 Mn |
| Mar 31, 2026 | 171.14 Mn |
| Dec 31, 2025 | 122.47 Mn |
| Sep 30, 2025 | 178.56 Mn |
| Jun 30, 2025 | 170.94 Mn |
| Mar 31, 2025 | 254.01 Mn |
| Dec 31, 2024 | 78.42 Mn |
| Sep 30, 2024 | 111.22 Mn |
| Jun 30, 2024 | 101.85 Mn |
| Mar 31, 2024 | 75.10 Mn |
| Dec 31, 2023 | 120.34 Mn |
| Sep 30, 2023 | 216.85 Mn |
| Jun 30, 2023 | 136.93 Mn |
| Mar 31, 2023 | 239.39 Mn |
| Dec 31, 2022 | 283.31 Mn |
| Sep 30, 2022 | 116.41 Mn |
| Jun 30, 2022 | 86.30 Mn |
| Mar 31, 2022 | 121.27 Mn |
| Dec 31, 2021 | 231.31 Mn |
| Sep 30, 2021 | 68.91 Mn |
API Access
Dr Reddys Laboratories Cash from Operations API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-operations&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-operations", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-operations&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();